PRF1 and Miyoshi myopathy: However, perforin/granzyme inhibitor CMA prevented the enhancement of NK cell–mediated lysis in the CFZ treated samples (Figure 5G), indicating that NK cell killing of MM cells after CFZ treatment was mediated by perforin/granzyme.